1. Home
  2. ORIC vs BUI Comparison

ORIC vs BUI Comparison

Compare ORIC & BUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • BUI
  • Stock Information
  • Founded
  • ORIC 2014
  • BUI 2011
  • Country
  • ORIC United States
  • BUI United States
  • Employees
  • ORIC N/A
  • BUI N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • BUI Trusts Except Educational Religious and Charitable
  • Sector
  • ORIC Health Care
  • BUI Finance
  • Exchange
  • ORIC Nasdaq
  • BUI Nasdaq
  • Market Cap
  • ORIC 545.5M
  • BUI 511.9M
  • IPO Year
  • ORIC 2020
  • BUI N/A
  • Fundamental
  • Price
  • ORIC $5.61
  • BUI $22.66
  • Analyst Decision
  • ORIC Strong Buy
  • BUI
  • Analyst Count
  • ORIC 9
  • BUI 0
  • Target Price
  • ORIC $18.43
  • BUI N/A
  • AVG Volume (30 Days)
  • ORIC 672.2K
  • BUI 59.8K
  • Earning Date
  • ORIC 05-05-2025
  • BUI 01-01-0001
  • Dividend Yield
  • ORIC N/A
  • BUI 6.79%
  • EPS Growth
  • ORIC N/A
  • BUI N/A
  • EPS
  • ORIC N/A
  • BUI 2.75
  • Revenue
  • ORIC N/A
  • BUI N/A
  • Revenue This Year
  • ORIC N/A
  • BUI N/A
  • Revenue Next Year
  • ORIC N/A
  • BUI N/A
  • P/E Ratio
  • ORIC N/A
  • BUI $7.77
  • Revenue Growth
  • ORIC N/A
  • BUI N/A
  • 52 Week Low
  • ORIC $5.53
  • BUI $18.73
  • 52 Week High
  • ORIC $14.67
  • BUI $24.22
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 30.76
  • BUI 46.38
  • Support Level
  • ORIC $5.78
  • BUI $22.46
  • Resistance Level
  • ORIC $8.11
  • BUI $22.85
  • Average True Range (ATR)
  • ORIC 0.52
  • BUI 0.25
  • MACD
  • ORIC -0.13
  • BUI -0.00
  • Stochastic Oscillator
  • ORIC 1.59
  • BUI 31.97

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About BUI BlackRock Utility Infrastructure & Power Opportunities Trust

BlackRock Utility Infrastructure & Power Opportunities Trust is a closed-end management investment company. Its investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities issued by companies that are engaged in the Utilities, Infrastructure and Power Opportunities business segments anywhere in the world and by employing of writing (selling) call and put options.

Share on Social Networks: